Coulie Bernard — SEC Form 4 filings
SEC reporting owner CIK 1808895. 11 Form 4 filings on record with FilingPulse; latest filed 2026-06-30.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-01-19 to 2026-06-30. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 4 legs across 4 filings — 206,225 shares, $1,592,211 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 22.
- Largest priced transaction: sale of 52,419 shares @ $11.20 ($587,150) in PLIANT THERAPEUTICS, INC., filed 2025-01-22.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | President and CEO, Director | 9 | — | 4 legs · 206,225 sh · $1,592,211 | 20 |
| Septerna, Inc. (SEPN) | Director | 2 | — | — | 2 |
Form 4 filings — Coulie Bernard
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-30 | 4 | Septerna, Inc. (SEPN) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2026-04-17 | 4 | PLIANT THERAPEUTICS, INC. (PLRX) | Disposition to issuer (D): 146,841 (derivative) @ $0 · Grant/award (A): 146,841 (derivative) @ $0 · Disposition to issuer (D): 327,262 (derivative) @ $0 · Grant/award (A): 327,262 (derivative) @ $0 · Disposition to issuer (D): 250,000 (derivative) @ $0 · Grant/award (A): 250,000 (derivative) @ $0 · +8 more | EDGAR |
| 2026-01-26 | 4 | PLIANT THERAPEUTICS, INC. (PLRX) | Grant/award (A): 1,230,000 (derivative) @ $0 | EDGAR |
| 2026-01-22 | 4 | PLIANT THERAPEUTICS, INC. (PLRX) | Sale (S): 89,375 @ $1.28 | EDGAR |
| 2025-06-20 | 4 | Septerna, Inc. (SEPN) | Grant/award (A): 16,623 (derivative) @ $0 | EDGAR |
| 2025-01-27 | 4 | PLIANT THERAPEUTICS, INC. (PLRX) | Grant/award (A): 162,500 @ $0 · Grant/award (A): 325,000 (derivative) @ $0 | EDGAR |
| 2025-01-22 | 4 | PLIANT THERAPEUTICS, INC. (PLRX) | Sale (S): 52,419 @ $11.20 | EDGAR |
| 2024-07-12 | 4 | PLIANT THERAPEUTICS, INC. (PLRX) | Sale (S): 38,710 @ $11.56 | EDGAR |
| 2024-07-11 | 4 | PLIANT THERAPEUTICS, INC. (PLRX) | Grant/award (A): 75,625 @ $0 | EDGAR |
| 2024-01-24 | 4 | PLIANT THERAPEUTICS, INC. (PLRX) | Grant/award (A): 128,150 @ $0 · Grant/award (A): 256,300 (derivative) @ $0 | EDGAR |
| 2024-01-19 | 4 | PLIANT THERAPEUTICS, INC. (PLRX) | Sale (S): 25,721 @ $17.23 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1808895 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →